K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Désirée van der Heijde
also known as D M F M van der Heijde, D M van der Heijde, D Van Der Heijde
Leiden University Medical Center · Roche (Switzerland) · Leiden University · Oslo University Hospital
About this author
Works
1,349
Cited by
118,307
h-index
159
i10
735
ORCID ↗
Top papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
·
2017
·
Annals of the Rheumatic Diseases
↗ 5,765
OA
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé, et al.
·
2009
·
Annals of the Rheumatic Diseases
↗ 3,587
OA
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, et al.
·
2000
·
New England Journal of Medicine
↗ 3,017
OA
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, et al.
·
2020
·
Annals of the Rheumatic Diseases
↗ 2,731
OA
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
Lars Klareskog, Désirée van der Heijde, J Jäger, et al.
·
2004
·
The Lancet
↗ 1,769
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, et al.
·
2013
·
Annals of the Rheumatic Diseases
↗ 1,760
OA
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, et al.
·
2022
·
Annals of the Rheumatic Diseases
↗ 1,703
OA
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos, et al.
·
2009
·
Annals of the Rheumatic Diseases
↗ 1,630
\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, et al.
·
2010
·
Radboud Repository (Radboud University)
↗ 1,624
OA
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Désirée van der Heijde, Sofía Ramiro, Robert Landewé, et al.
·
2017
·
Annals of the Rheumatic Diseases
↗ 1,551
OA
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S Smolen, Ferdinand C. Breedveld, Gerd R Burmester, et al.
·
2015
·
Annals of the Rheumatic Diseases
↗ 1,445
OA
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
E. William St. Clair, Désirée van der Heijde, Josef S Smolen, et al.
·
2004
·
Arthritis & Rheumatism
↗ 1,165
Books
Fast Facts
2004
·
Karger AG, S.